Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-24T13:49:09.160Z Has data issue: false hasContentIssue false

Volume replacement with gelatin or hydroxyethylstarch solutions does not impair somatosensory evoked potential monitoring: A haemodilution study in conscious volunteers

Published online by Cambridge University Press:  04 August 2006

O. Detsch
Affiliation:
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany
J. Mühling
Affiliation:
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany
B. Bachmann-Mennenga
Affiliation:
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany
A. Thiel
Affiliation:
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany
M. Heesen
Affiliation:
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany
G. Hempelmann
Affiliation:
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany
Get access

Abstract

The influence of haemodilution with colloids on somatosensory evoked potentials in non-premedicated volunteers is reported. In seven volunteers (randomized crossover design), blood (20 mL kg−1 within 30 min) was removed and simultaneously replaced by gelatin 3% or hydroxyethylstarch 6%. After 30 min, blood was retransfused within 30 min. Median and posterior tibial nerve somatosensory evoked potentials were recorded from the cortex, second cervical vertebra, Erb's point and 1st lumbar vertebra, respectively. One volunteer experienced a severe allergic reaction to gelatin, therefore only six gelatin trials were evaluated. Haemodilution decreased the haematocrit from 39.8 ± 1.6% (mean ± SD) to 31.1 ± 2.0% (gelatin) and from 40.7 ± 1.7% to 29.8 ± 1.5% (hydroxyethylstarch), respectively. Retransfusion increased haematocrit to 34.4 ± 0.9% (gelatin) and to 34.2 ± 1.3% (hydroxyethylstarch). Neither haemodilution with gelatin nor haemodilution with hydroxyethylstarch or retransfusion influenced evoked potentials. In conclusion, the treatment of blood loss up to 30% of estimated blood volume with gelatin or hydroxyethylstarch will not affect somatosensory evoked potential monitoring provided normovolaemic conditions are maintained.

Type
Original Article
Copyright
1996 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)